Cytotoxic effects of coumarin substituted benzimidazolium salts against human prostate and ovarian cancer cells
dc.authorid | ALICI, Bulent/0000-0001-5009-3223 | |
dc.authorid | Sandal, Suleyman/0000-0002-8916-3329 | |
dc.authorid | Tekin, Suat/0000-0002-2757-1802 | |
dc.authorid | Karataş, Mert Olgun/0000-0001-8500-2088; | |
dc.authorwosid | ALICI, Bulent/AAG-4203-2019 | |
dc.authorwosid | Sandal, Suleyman/AAA-6388-2021 | |
dc.authorwosid | Tekin, Suat/IZD-9868-2023 | |
dc.authorwosid | Tekin, Suat/KEI-2266-2024 | |
dc.authorwosid | Karataş, Mert Olgun/ABG-7848-2020 | |
dc.authorwosid | Tekin, Suat/AAG-1440-2021 | |
dc.contributor.author | Karatas, Mert Olgun | |
dc.contributor.author | Tekin, Suat | |
dc.contributor.author | Alici, Bulent | |
dc.contributor.author | Sandal, Suleyman | |
dc.date.accessioned | 2024-08-04T20:46:06Z | |
dc.date.available | 2024-08-04T20:46:06Z | |
dc.date.issued | 2019 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Coumarin and benzimidazole derivatives have individual biological activities including anticancer. In this study, we aimed to synthesize coumarin-benzimidazole hybrids in order to investigate their anticancer properties. For this purpose, six 6-substituted-4-chloromethylene coumarin derivatives were synthesized. Sixteen coumarin substituted benzimidazolium chlorides were synthesized by the reaction of 4-chloromethylene coumarin and N-benzylbenzimidazole derivatives. All of the synthesized compounds were characterized by 1H and 13C NMR, IR spectroscopic techniques and elemental analyses. Cytotoxicities of all compounds were tested by [ 3-(4,5-dimethylthiazole)-2-yl]-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay against human prostate (PC-3) and ovarian (A2780) cancer cells. All compounds performed significant cytotoxicities at 100 mu Magainst both cancer cell lines. Moreover, some compounds performed significant activities at 1 mu M against both cancer cell lines and the obtained results suggest that this type of compounds are promising candidates for the treatment of human prostate and ovarian cancers. | en_US |
dc.identifier.doi | 10.1007/s12039-019-1647-0 | |
dc.identifier.issn | 0974-3626 | |
dc.identifier.issn | 0973-7103 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.scopus | 2-s2.0-85070019596 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s12039-019-1647-0 | |
dc.identifier.uri | https://hdl.handle.net/11616/98893 | |
dc.identifier.volume | 131 | en_US |
dc.identifier.wos | WOS:000480284000001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Indian Acad Sciences | en_US |
dc.relation.ispartof | Journal of Chemical Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Benzimidazole | en_US |
dc.subject | benzimidazolium salt | en_US |
dc.subject | coumarin | en_US |
dc.subject | cytotoxicity | en_US |
dc.title | Cytotoxic effects of coumarin substituted benzimidazolium salts against human prostate and ovarian cancer cells | en_US |
dc.type | Article | en_US |